Among the identified FRGs, MYBPH, SOST, SPRR2A, and CRNN were notably upregulated in the high-risk group, implying their potential involvement as cancer-promoting genes in BLCA development. The gene discussed is CRNN; the disease is bladder transitional cell carcinoma.